Close Menu

marketing agreement

Under the terms of the agreement, Sciex has exclusive reseller and marketing rights to the XCMSplus software.

The partners will jointly promote the BD FACS single-cell sorting instrument alongside Cellular Research's molecular bar-coding technology, Precise.

LifeMap will promote Toldot's products to academic researchers, research hospitals, and biopharmaceutical firms.

PerkinElmer's liquid and gas chromatography portfolio will be standardized on Waters' Empower Software.

NEW YORK (GenomeWeb) – Rosetta Genomics today announced a deal to sell tests from Admera Health to oncologists and pathologists.

NEW YORK (GenomeWeb) – VHLGenetics today announced an agreement with Labocor to market VHLGenetics' products in Spain.

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

NEW YORK (GenomeWeb) – Lucigen announced yesterday that it has partnered with Thermo Fisher Scientific to develop and launch a long mate pair library kit for the Ion Torrent Personal Genome Machine sequencing platform.

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific to bring a rapid, cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries, ATCC said today.

NEW YORK (GenomeWeb) – Cancer Genetics today said that it has signed a multi-year agreement with PathAdvantage Associated to offer its FHACT test, a FISH-based genomic test for detecting and managing cervical cancer, and to collaborate on research in support of the test.

Pages

Bloomberg reports that vaccine developers won't have to conduct large trials of updated vaccines or vaccine boosters aimed at new viral variants.

The SARS-CoV-2 variant uncovered in California may be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.

Francis deSouza, the CEO of Illumina, calls for a global SARS-CoV-2 genomics surveillance network, according to the Financial Times.

In PNAS this week: immunotherapy for hard-to-treat breast cancers, effects of oncogenic histone H3K36M mutations, and more.